This PRA Insights report focusing on Alzheimer’s disease research was compiled from survey data gathered at the 2017 Alzheimer’s Association International Conference (AAIC). The aim of the survey was to gather insight on clinical development and the future of research in Alzheimer’s disease from pharma and biotech, academic researchers, next generation investigators, clinicians and the care research community involved in the prevention and treatment of Alzheimer’s disease and other dementias.
Explore related content and topics
Poster
Retrospective Analysis of the Effects of Protocol Design on Completion Rates in Phase 1 Studies in Subjects with Stable Schizophrenia
Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in meta-analysis to be as high as 76% (Robinowitz…
Blog
5 Tips for Healthy Social Distancing
Social distancing is a new term for us all—and now we hear it every day. According to PRA’s Dr. Greg Licholai, Chief Medical Information Officer,…
Infographic
Alzheimers Disease Infographic
Alzheimer's Disease is the most common type of dementia accounting for 60%-80% of all cases. In the past 5 years, PRA has conducted numerous clinical…